Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OXFD

Oxford Immunotec Global (OXFD) Stock Price, News & Analysis

Oxford Immunotec Global logo

About Oxford Immunotec Global Stock (NASDAQ:OXFD)

Advanced Chart

Key Stats

Today's Range
$21.99
$21.99
50-Day Range
$21.88
$21.99
52-Week Range
$8.37
$23.11
Volume
N/A
Average Volume
1.10 million shs
Market Capitalization
$570.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OXFD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Immunotec Global and its competitors with MarketBeat's FREE daily newsletter.

OXFD Stock News Headlines

A Game-Changing Vaccine
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Nigeria rolls out new Oxford R21 malaria vaccine
See More Headlines

OXFD Stock Analysis - Frequently Asked Questions

Oxford Immunotec Global PLC (NASDAQ:OXFD) announced its quarterly earnings results on Tuesday, November, 3rd. The company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The firm earned $19.44 million during the quarter, compared to the consensus estimate of $18.58 million. Oxford Immunotec Global had a negative net margin of 30.51% and a negative trailing twelve-month return on equity of 8.39%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Immunotec Global investors own include Intel (INTC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Dynavax Technologies (DVAX), Enterprise Products Partners (EPD) and Gold Resource (GORO).

Company Calendar

Last Earnings
11/03/2020
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:OXFD
Fax
N/A
Employees
273
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.81 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$73.71 million
Cash Flow
$0.02 per share
Price / Cash Flow
1,408.78
Book Value
$8.08 per share
Price / Book
2.72

Miscellaneous

Free Float
N/A
Market Cap
$570.90 million
Optionable
Not Optionable
Beta
1.42
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:OXFD) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners